β-Patchoulene
β-Patchoulene is an orally active anti-inflammatory, antioxidant, and anti-apoptotic agent. β-Patchoulene inhibits the NF-κB, TLR4, and cAMP/PKA/CREB signaling pathways; activates the Sirt1/Nrf2 and AMPK signaling pathways; and targets Fas/FasL, Caspase-3, ERK1/2, ROCK1/MLC2 for inhibition. β-Patchoulene regulates cytokine secretion, inflammatory cell infiltration, lipid peroxidation, cell polarization, gut microbiota, and lipid metabolism, restores barrier function, mitochondrial function, and cell viability, and exhibits repellent activity against Spodoptera exigua larvae. β-Patchoulene can be used in research related to various inflammatory, ischemic, fibrosis-associated diseases, as well as hepatocellular carcinoma.
For research use only. We do not sell to patients.
- CAS No.: 514-51-2
- Formula: C15H24
- Molecular Weight:204.35
-
Storage:
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Biological Activity
Description
|
NF-κB |
TLR4 |
PKA |
SIRT1 |
AMPK |
Caspase-3 |
ERK1 |
ERK2 |
ROCK-1 |
In Vitro
β-Patchoulene (10-100 μmol/L) exhibits no significant cytotoxicity to human GES-1 gastric epithelial cells at concentrations up to 80 μmol/L[2].
β-Patchoulene (10-40 μmol/L; 4 h pre-incubation, 24 h co-cultivation with ethanol) pre-treatment significantly improves cell viability of ethanol-injured human GES-1 gastric epithelial cells[2].
β-patchoulene (5-50 μM; 1 h pre-incubation) dose-dependently suppresses pro-inflammatory cytokine production, oxidative stress, and apoptosis in H/R-injured cultured macrophages by enhancing Nrf2 nuclear translocation and HO-1 expression while inhibiting NF-κB p-P65 expression[5].
β-Patchoulene (0.1-160 μM; 24 or 48 h) exhibits no cytotoxicity to rat intestinal epithelial IEC-6 cells[8].
β-Patchoulene (20-80 μM; 24 h) significantly recovers the viability of 5-Fluorouracil (HY-90006)-injured rat intestinal epithelial IEC-6 cells[8].
β-Patchoulene (20 μM; 24 h) suppresses AQP3 expression and inactivates the cAMP/PKA/CREB signaling pathway in 5-FU-treated rat intestinal epithelial IEC-6 cells[8].
β-Patchoulene (10-100 μM; 24 h) is non-cytotoxic to human hepatocyte L02 cells with significant cytotoxicity observed only at 100 μM[9].
β-Patchoulene (40 μM; 24 h) significantly attenuates FFA-induced lipid accumulation in human hepatocyte L02 cells via activating the AMPK signaling pathway[9].
β-Patchoulene (0.3125-20 μM; 48 h) suppresses the viability and proliferation of human HCC Huh-7 and MHCC97 cells in a dose-dependent manner[10].
β-Patchoulene (2.5 μM; 48 h) restrains proliferation, facilitates apoptosis, suppresses invasion and EMT, and inactivates the NF-κB/HIF-1α signaling pathway in hypoxia-stimulated human HCC Huh-7 and MHCC97 cells via regulating related protein expressions[10].
β-Patchoulene was the main product of the reaction where recombinant DoPAES protein[12].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human GES-1 gastric epithelial cells (ethanol-induced injury)
-
Concentration:10, 20, 40 μmol/L
-
Incubation Time:4 h (pre-incubation); 24 h (co-cultivation with ethanol)
-
Result:Increased cell viability in ethanol-exposed GES-1 cells to 66.96% at 10 μmol/L.
Increased cell viability in ethanol-exposed GES-1 cells to 69.81% at 20 μmol/L.
Increased cell viability in ethanol-exposed GES-1 cells to 73.31% at 40 μmol/L.
-
Cell Line:Cultured Macrophages
-
Concentration:5 μM, 50 μM
-
Incubation Time:1 h (pre-incubation)
-
Result:Promoted nuclear Nrf2 translocation in H/R-injured macrophages in a dose-dependent manner.
Upregulated HO-1 protein expression in H/R-injured macrophages in a dose-dependent manner.
Inhibited NF-κB p-P65 protein expression in H/R-injured macrophages in a dose-dependent manner.
-
Cell Line:rat intestinal epithelial IEC-6 cells
-
Concentration:0.1, 1, 10, 20, 40, 60, 80, 160 μM
-
Incubation Time:24 h; 48 h
-
Result:Showed no cytotoxicity to IEC-6 cells at all tested concentrations over 24 and 48 h, with cell viability remaining near 100% relative to the control group.
-
Cell Line:5-fluorouracil (5-FU)-injured rat intestinal epithelial IEC-6 cells
-
Concentration:20, 40, 80 μM
-
Incubation Time:24 h
-
Result:Significantly restored the viability of 5-FU-injured IEC-6 cells.
-
Cell Line:5-FU-treated rat intestinal epithelial IEC-6 cells
-
Concentration:20 μM
-
Incubation Time:24 h (post 8-Br-cAMP induction)
-
Result:Suppressed overexpression of AQP3 and PKA, and inhibited phosphorylation of MEK1/2, MSK1, and CREB compared to the 5-FU-only group.
Had effects counteracted by the PKA agonist 8-Br-cAMP via upregulation of related protein expression or phosphorylation.
-
Cell Line:human hepatocyte L02 cells
-
Concentration:10 μM, 20 μM, 40 μM, 80 μM, 100 μM
-
Incubation Time:24 h
-
Result:Shows no significant reduction in cell viability at concentrations up to 80 μM relative to the normal control group.
Causes a significant decrease in cell viability at 100 μM concentration.
-
Cell Line:human hepatocellular carcinoma Huh-7, MHCC97 cells
-
Concentration:0.3125, 0.625, 1.25, 2.5, 5, 10 μM
-
Incubation Time:48 h
-
Result:Reduced the viability of Huh-7 and MHCC97 cells in a concentration-dependent manner.
-
Cell Line:human hepatocellular carcinoma Huh-7, MHCC97 cells
-
Concentration:0.3125, 0.625, 1.25, 2.5, 5, 10 μM
-
Incubation Time:48 h (treatment), followed by 2 weeks of culture
-
Result:Decreased the colony-forming ability of Huh-7 and MHCC97 cells in a concentration-dependent manner.
-
Cell Line:hypoxia-induced human hepatocellular carcinoma Huh-7, MHCC97 cells
-
Concentration:2.5 μM
-
Incubation Time:48 h
-
Result:Significantly increased the apoptotic rate of hypoxia-induced Huh-7 and MHCC97 cells compared to the hypoxia-only group.
Downregulated the expression of the anti-apoptotic protein Survivin, which was upregulated by hypoxia.
In Vivo
β-Patchoulene (10-40 mg/kg; i.g.; daily; 7 days) dose-dependently protects against ethanol-induced gastric ulcer in male Sprague Dawley rats, anti-inflammatory, anti-apoptotic, and signalling pathway-modulating mechanisms[2].
β-Patchoulene (0.2-1 mg/kg; i.c.v.; single dose immediately post-CLP) significantly improves cognitive function, reduces neuroinflammation and oxidative stress, inhibits microglia activation and M1 polarization, enhances Sirt1/Nrf2/HO-1 pathway activity, reduces splenic lymphocyte apoptosis[3].
β-Patchoulene (10-40 mg/kg; i.g.; daily; 7 days) dose-dependently inhibits xylene-induced ear edema in KM mice[4].
β-Patchoulene (10-40 mg/kg; i.g.; daily; 7 days) dose-dependently reduces acetic acid-induced vascular permeability in KM mice[4].
β-Patchoulene (10-40 mg/kg; i.g.; daily; 7 days) exerts potent, dose-dependent anti-inflammatory effects in carrageenan-induced paw edema in KM mice, mediated via suppression of pro-inflammatory mediators, oxidative stress, and NF-κB signaling[4].
β-Patchoulene (10 mg/kg; i.v.; single dose 2 hours before surgery) preconditioning protects male C57BL/6 mice against hepatic ischemia-reperfusion injury by reducing liver enzyme release, inflammation, oxidative stress, and apoptosis, with concurrent activation of the Nrf2/HO-1 pathway and inhibition of NF-ƘB signaling[5].
β-Patchoulene (10 mg/kg; i.v.; single pretreatment dose 1 h before surgery) exerts neuroprotective effects against cerebral ischemia-reperfusion injury in Sprague-Dawley rats, as evidenced by reduced infarct volume, brain edema, neurological deficits, apoptosis, inflammation, and oxidative stress, via inactivation of the TLR4/NF-κB signaling pathway[6].
β-Patchoulene (5-20 mg/kg; p.o.; daily; 7 days) dose-dependently ameliorates DSS-induced ulcerative colitis and secondary liver injury in male BALB/c mice by suppressing colonic leakage, inhibiting inflammatory signaling pathways, and restoring gut microbiota homeostasis, with the 20 mg/kg dose producing the most robust effects across all measured endpoints[7].
β-Patchoulene (10-40 mg/kg; p.o.; daily; 7 days) dose-dependently ameliorates 5-Fluorouracil (HY-90006)-induced intestinal mucositis in male Sprague Dawley rats, with 40 mg/kg oral gavage achieving the strongest effects on improving body characteristics, intestinal histopathology, suppressing inflammation, restoring the mucus barrier, and inhibiting the cAMP/PKA/CREB signaling pathway to reduce AQP3 expression[8].
β-Patchoulene (40 mg/kg; p.o.; daily; 7 days) ameliorates 5-Fluorouracil (HY-90006)-induced intestinal mucositis in male Sprague Dawley rats[8].
β-Patchoulene (10-40 mg/kg; i.g.; daily; 4 weeks) activates AMPK signaling to inhibit hepatic lipid synthesis and promote mitochondrial lipid oxidation, significantly alleviating HFD-induced NAFLD in rats[9].
β-Patchoulene (5-20 μmol/kg) dose-dependently reduces hepatocellular carcinoma tumor growth, induces tumor cell apoptosis, inhibits epithelial-mesenchymal transition, and inactivates the NF-κB/HIF-1α pathway in hypoxic nude mouse models[10].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Kunming (KM) (male, 18-22 g, LPS-induced ALI)[1]
-
Dosage:2.5 mg/kg; 5 mg/kg; 10 mg/kg
-
Administration:p.o.; once daily; 7 days
-
Result:Decreased LPS-induced mouse mortality effectively.
Lessened pulmonary edema and improved multiple pathological lesions in lung tissues.
Downregulated pulmonary oxidative stress levels and inflammatory cytokine secretion.
Suppressed the activation of NF-κB inflammatory signaling pathway.
Promoted the activation of Nrf2 antioxidant signaling pathway.
Upregulated the expression level of miR-146a in lung tissues.
-
Animal Model:Sprague Dawley (male, 180-220 g, ethanol-induced gastric ulcer)[2]
-
Dosage:10 mg/kg; 20 mg/kg; 40 mg/kg
-
Administration:i.g.; daily; 7 days
-
Result:Reduced gastric ulcer area in a dose-dependent manner with obvious inhibition effect.
Lowered histological total microscopic score in a dose-dependent manner, alleviating epithelial damage and submucosal oedema.
Improved SOD activity, enhanced CAT activity, increased GSH level, decreased MDA level, and reduced serum levels of TNF-α, IL-1β and IL-6 at all doses.
Downregulated Fas, FasL, and caspase-3 IODs in a dose-dependent manner at all doses.
Inhibited increased p-p65/p65 and p-IκB/IκB ratios at the highest dose.
Enhanced p-ERK1/2/ERK1/2 ratio at the highest dose.
Upregulated c-fos mRNA, c-jun mRNA, and miR-21 expression at the highest dose.
-
Animal Model:C57BL/6 (male, 6-10 weeks old, sepsis associated encephalopathy induced by cecal ligation and puncture surgery)[3]
-
Dosage:0.2 mg/kg; 1 mg/kg
-
Administration:i.c.v.; single dose immediately post-CLP
-
Result:Elevated behavioral and cognitive related indicators at multiple time points after CLP operation at 1 mg/kg, and effectively raised the survival rate of model mice.
Reduced cerebral inflammatory factors and oxidative stress levels without affecting anti-inflammatory factor expression, and inhibited hippocampal microglial M1 polarization.
Regulated the expression of Sirt1/Nrf2 pathway-related proteins and relieved hippocampal neuronal apoptosis.
Alleviated systemic inflammatory response and suppressed splenic lymphocyte apoptosis.
Low-dose treatment could partially ameliorate cognitive dysfunction.
-
Animal Model:Kun Ming (KM) (male and female, 18-22 g)[4]
-
Dosage:10 mg/kg; 20 mg/kg; 40 mg/kg
-
Administration:i.g.; daily; 7 days
-
Result:Inhibited xylene-induced ear edema and acetic acid-triggered vascular permeability in a dose-dependent manner, and relieved carrageenan-caused paw edema with obvious long-term inhibitory effects.
Alleviated pathological swelling, tissue damage and inflammatory cell infiltration, and improved tissue fibrous structure.
Lowered paw tissue MDA and MPO contents effectively.
Reduced the release of multiple pro-inflammatory cytokines and inflammatory mediators.
Downregulated the expression levels of iNOS and COX-2 proteins.
Stabilized IκBα to block NF-κB signaling pathway activation and restrain nuclear translocation of p65.
-
Animal Model:C57BL/6 (male, 8-10 weeks old)[5]
-
Dosage:10 mg/kg
-
Administration:i.v.; single dose 2 hours before surgery
-
Result:Lowered serum ALT and AST levels and alleviated liver pathological injury in hepatic ischemia-reperfusion mice.
Inhibited hepatic inflammatory cytokine expression and reduced inflammatory factor-positive macrophages.
Mitigated hepatic oxidative stress and restrained hepatocyte apoptosis.
Suppressed M1 polarization of Kupffer cells.
Activated Nrf2/HO-1 antioxidant pathway and inhibited NF-κB p65 phosphorylation.
-
Animal Model:Sprague-Dawley (male, 8 weeks old, 80-120 g, middle cerebral artery occlusion for 2 h followed by 24 h reperfusion)[6]
-
Dosage:10 mg/kg
-
Administration:i.v.; single pretreatment dose 1 h before surgery
-
Result:Reduced cerebral infarct volume, brain edema and neurological deficits, and recovered mitochondrial membrane potential in cerebral ischemia-reperfusion injured rats.
Declined neuronal apoptosis rate, regulated BAX/Bcl-2 balance and lowered caspase-3 activity.
Downregulated inflammatory factor expression, relieved oxidative stress damage and improved antioxidant enzyme activity.
Blocked the TLR4/NF-κB pathway via modulating related protein expression and restricting p65 nuclear translocation.
-
Animal Model:BALB/c (male, 21-25 g, induced with 3% dextran sulfate sodium in drinking water ad libitum for 7 days)[7]
-
Dosage:5 mg/kg; 10 mg/kg; 20 mg/kg
-
Administration:p.o.; daily; 7 days
-
Result:Improved general disease conditions and relieved colon tissue damage in a dose-dependent manner, and alleviated colon shortening at medium and high doses.
Inhibited intestinal cell apoptosis and upregulated intestinal barrier-related gene expression at medium and high doses.
Lowered colonic inflammatory mediators and adhesion molecule contents, and restrained multiple inflammatory signaling pathways.
Declined local and systemic lipopolysaccharide levels, and regulated various serum inflammatory and liver function related indicators.
Ameliorated liver inflammatory lesions and reduced hepatic inflammatory factor release in a dose-related way.
Restored intestinal microbial diversity and optimized gut flora structure at high dose.
-
Animal Model:Sprague Dawley (male, 180-220 g, 5-fluorouracil-induced intestinal mucositis)[8]
-
Dosage:10 mg/kg; 20 mg/kg; 40 mg/kg
-
Administration:p.o.; daily; 7 days
-
Result:Promoted body weight gain and improved food intake at medium and high doses, and relieved diarrhea symptoms at all doses in 5-FU induced model rats.
Optimized intestinal tissue morphological structure and alleviated intestinal pathological damage at all doses.
Regulated intestinal inflammatory factor levels effectively at medium and high doses.
Elevated intestinal mucin secretion and increased goblet cell quantity to enhance intestinal mucosal barrier function.
Downregulated the expression of related functional proteins and restrained the activation of multiple downstream signaling pathways in a dose-dependent manner.
-
Animal Model:Sprague Dawley (male, 180-220 g, 5-fluorouracil-induced intestinal mucositis)[8]
-
Dosage:40 mg/kg
-
Administration:p.o.; daily; 7 days
-
Result:Promoted body weight gain and improved food intake at medium and high doses, and relieved diarrhea symptoms at all doses in 5-FU induced model rats.
Optimized intestinal tissue morphological structure and alleviated intestinal pathological damage at all doses.
Reduced intestinal TNF-α, IL-1β, IL-6 and IL-10 contents obviously at medium and high doses.
Elevated intestinal MUC2 mucin level and goblet cell number to strengthen intestinal mucosal barrier function.
Downregulated the expression of related functional proteins and inhibited the activation of MEK/ERK/p38 signaling cascades at all doses with dose-dependent effects.
-
Animal Model:Sprague Dawley (male, 180−220 g, NAFLD induced by 60% fat high-fat diet for 4 weeks)[9]
-
Dosage:10 mg/kg; 20 mg/kg; 40 mg/kg
-
Administration:i.g.; daily; 4 weeks
-
Result:Reduced liver index without affecting body weight gain at low dose, while middle and high doses decreased both body weight gain and liver index in HFD-fed models.
Improved serum levels of ALT, AST, HDL-C, LDL-C, TG and TC, and lowered hepatic TG, TC and NEFA contents at all tested doses.
Alleviated hepatic pathological lesions and decreased lipid deposition area in liver tissues.
Suppressed the expression of hepatic lipid synthesis related proteins and genes including SREBP-1c, HMG-CR, FASN and SCD1, and regulated ACC1 phosphorylation level.
Elevated hepatic antioxidant capacity by decreasing MDA content and raising GSH-Px and SOD activities, and upregulated lipid oxidation markers SIRT1, PPARα and CPT-1a with no obvious influence on ACOX1 expression.
Activated AMPK signaling pathway by elevating p-AMPKα/AMPKα ratio and AMPKα mRNA expression in liver tissues in a dose-dependent manner.
Chemical Information
-
CAS No. 514-51-2
-
Appearance Liquid (Density: 0.951±0.10 g/cm3)
-
Molecular Weight 204.35
-
Formula C15H24
-
Color Colorless to light yellow
-
SMILES
C[C@]1(CC2)C(CC[C@@H]3C)=C3C[C@]2([H])C(C)1C
-
Structure Classification
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Protocols
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
-
Research Protocol for Microbiome Analysis
Microbiome analysis characterizes microbial communities in biological or environmental samples by measuring community composition, diversity, taxonomic structure, functional potential, and associations with host or environmental phenotypes. 16S rRNA gene amplicon sequencing is commonly used for bacterial and archaeal taxonomic profiling, while shotgun metagenomics provides higher taxonomic resolution and direct functional information, including microbial genes, pathways, viruses, fungi, and antimicrobial-resistance genes when sequencing depth and host-DNA contamination are adequately controlled. Microbiome results are strongly affected by sample collection, storage, DNA extraction, contamination, sequencing method, reference database, and bioinformatic pipeline; therefore, standardized protocols, negative controls, mock communities, and transparent analysis workflows are required. Unresolved issues include low-biomass contamination, compositional-data bias, inconsistent species-level c
-
CCK-8/WST-8 Cell Proliferation Assay
The CCK-8/WST-8 assay is based on the reduction of the water-soluble tetrazolium salt WST-8 to a water-soluble formazan product by cellular dehydrogenases in metabolically active cells, where the generated formazan amount is proportional to the number of living cells and is quantified by measuring absorbance in the visible range, providing a colorimetric readout for cell viability and proliferation assessment. This class of tetrazolium-based assays improves upon earlier MTT-based systems by producing a water-soluble formazan, eliminating the need for organic solubilization steps and enabling direct spectrophotometric measurement in culture medium.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
MTT Cell Proliferation Assay
The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.
Purity & Documentation
-
Data Sheet (310 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Chen XY, et al. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways. Int Immunopharmacol. 2017;50:270-278. [Content Brief]
[2]. Liu Y, et al. Transformation of patchouli alcohol to β-patchoulene by gastric juice: β-patchoulene is more effective in preventing ethanol-induced gastric injury. Sci Rep. 2017;7(1):5591. [Content Brief]
[3]. Tian Y, et al. β-patchoulene alleviates cognitive dysfunction in a mouse model of sepsis associated encephalopathy by inhibition of microglia activation through Sirt1/Nrf2 signaling pathway. PLoS One. 2023;18(1):e0279964. [Content Brief]
[4]. Zhang Z, et al. Anti-inflammatory activity of β-patchoulene isolated from patchouli oil in mice. Eur J Pharmacol. 2016;781:229-238. [Content Brief]
[5]. Tao T, et al. β-Patchoulene Preconditioning Protects Mice Against Hepatic Ischemia-Reperfusion Injury by Regulating Nrf2/HO-1 Signaling Pathway. J Surg Res. 2022;275:161-171. [Content Brief]
[6]. Zhang FB, et al. Effect of β-patchoulene on cerebral ischemia-reperfusion injury and the TLR4/NF-κB signaling pathway. Exp Ther Med. 2019;17(5):3335-3342. [Content Brief]
[8]. Wu J, et al. β-Patchoulene Ameliorates Water Transport and the Mucus Barrier in 5-Fluorouracil-Induced Intestinal Mucositis Rats via the cAMP/PKA/CREB Signaling Pathway. Front Pharmacol. 2021;12:689491. [Content Brief]
[9]. Xu N, et al. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway. Biomed Pharmacother. 2021;134:111104. [Content Brief]
[10]. Tu H, et al. β-Patchoulene represses hypoxia-induced proliferation and epithelial-mesenchymal transition of liver cancer cells. Bioengineered. 2022;13(5):11907-11922. [Content Brief]
[11]. Pu Q, et al. A Wheat β-Patchoulene Synthase Confers Resistance Against Herbivory in Transgenic Arabidopsis. Genes (Basel). 2019;10(6):441. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- β-Patchoulene
- 514-51-2
- NF-κB
- Toll-like Receptor (TLR)
- PKA
- Epigenetic Reader Domain
- Keap1-Nrf2
- Sirtuin
- AMPK
- Caspase
- FASTK
- ERK
- ROCK
- Apoptosis
- human GES-1 gastric epithelial cells
- gastric ulcer
- rat intestinal epithelial IEC-6 cells
- human HCC MHCC97 cells
- human hepatocyte L02 cells
- sepsis associated encephalopathy
- Nrf2
- acute lung injury
- human HCC Huh-7 cells
- Inhibitor
- inhibitor
- inhibit